http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2095064-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f03cffdee00cc69a7eb39695f836ffc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9d2f14ed981a6ae4f26436a57739635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96336222a89e9c34198867265d53cac3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_944ea1dab3876adecb8b351d7b02eecf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09170ab5b0088c4a3bfd31436801260f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2600d94d01746f80821be902e2c41d7c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
filingDate 1995-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1997-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_655e89bc57a060d3923c76e59dcd1be0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca9a428c7b128df344f626d70c00ad65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7d29f75857990f1cfa123ebe27915e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aba6ba04a03960b897c199de37292816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a670401e6bebcc4a6b01a592b9d7c78c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_583eb6eb76df204bb8269d42968c3efd
publicationDate 1997-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2095064-C1
titleOfInvention Agent for platelet aggregation decrease in circulatory system
abstract FIELD: medicine, cardiology, neurology, rheumatology. SUBSTANCE: agent has the following composition, wt. -%: acetylsalicylic acid 28.70-38.70; polymer-carrier 22-32; glucose 22-32; calcium gluconate 2.20-3.20; lipophilic agent 7.60-8.60, and plasticizing agent - 1.00-2.00. Acetylsalicylic acid is immobilized on polymer-carrier. Agent is made as buccal medicinal formula. EFFECT: enhanced effectiveness of agent. 3 cl, 3 tbl, 3 dwg
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2445045-C1
priorityDate 1995-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18502861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3014294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420320451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452283241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451114410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450362511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280427

Total number of triples: 46.